日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pharmacokinetics, Pharmacodynamics, and Bioequivalence of Test Insulin Glargine Versus Reference Preparation (Lantus(®)) in Healthy Male Volunteers-By Euglycemic Clamp Technique

采用正常血糖钳夹技术,在健康男性志愿者中研究试验用胰岛素甘精与参比制剂(来得时®)的药代动力学、药效学和生物等效性。

Li, Zhongping; Liu, Min; Tao, Yi; Wan, Lei; Chen, Yuan; Zhu, Mingxue; Zhao, Hongtao; Tang, Chengyong

Pharmacokinetics and pharmacodynamics of insulin lispro 25 versus the original preparation (Humalog(®)25) in Chinese healthy male volunteers

中国健康男性志愿者中赖脯胰岛素25与原制剂(优泌乐®25)的药代动力学和药效学比较

Zhu, Mingxue; Chen, Yuan; Wan, Lei; Li, Zhongping; Pu, Junliang; Tang, Chengyong

Study on bioequivalence and influence of obesity-related indicators on pharmacokinetics and pharmacodynamics for insulin degludec in healthy subjects

胰岛素德谷在健康受试者中的生物等效性研究及肥胖相关指标对其药代动力学和药效学的影响

Su, Rui; Wan, Lei; Tao, Yi; Zhu, Mingxue; Pu, Junliang; Li, Zhongping; Chen, Yuan; Tang, Chengyong

Artificial intelligence-assisted ultrasound image analysis to discriminate early breast cancer in Chinese population: a retrospective, multicentre, cohort study

人工智能辅助超声图像分析鉴别中国人群早期乳腺癌:一项回顾性、多中心队列研究

Liao, Jianwei; Gui, Yu; Li, Zhilin; Deng, Zijian; Han, Xianfeng; Tian, Huanhuan; Cai, Li; Liu, Xingyu; Tang, Chengyong; Liu, Jia; Wei, Ya; Hu, Lan; Niu, Fengling; Liu, Jing; Yang, Xi; Li, Shichao; Cui, Xiang; Wu, Xin; Chen, Qingqiu; Wan, Andi; Jiang, Jun; Zhang, Yi; Luo, Xiangdong; Wang, Peng; Cai, Zhigang; Chen, Li

Reduction in C-Peptide Levels and Influence on Pharmacokinetics and Pharmacodynamics of Insulin Preparations: How to Conduct a High-Quality Euglycemic Clamp Study

C肽水平降低及其对胰岛素制剂药代动力学和药效学的影响:如何开展高质量的正常血糖钳夹试验

Tao, Yi; Zhu, Mingxue; Pu, Junliang; Zhang, Peilin; Wan, Lei; Tang, Chengyong

Soluble fibrinogen-like protein 2 ameliorates acute rejection of liver transplantation in rat via inducing Kupffer cells M2 polarization

可溶性纤维蛋白原样蛋白2通过诱导库普弗细胞M2极化来改善大鼠肝移植的急性排斥反应

Pan, Guangrui; Zhao, Zhengfei; Tang, Chengyong; Ding, Liuyue; Li, Zhongtang; Zheng, Daofeng; Zong, Liang; Wu, Zhongjun

MiR-101 targets DUSP1 to regulate the TGF-β secretion in sorafenib inhibits macrophage-induced growth of hepatocarcinoma.

miR-101 靶向 DUSP1 以调节 TGF-β 分泌,索拉非尼抑制巨噬细胞诱导的肝癌细胞生长

Wei Xufu, Tang Chengyong, Lu Xiuxian, Liu Rui, Zhou Mi, He Diao, Zheng Daofeng, Sun Chao, Wu Zhongjun